The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma
The agreement provided that the Connecticut-based company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention. The high court had put the settlement on hold last summer, after the Biden administration objected.
